In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schott Aims For China’s High-End Pharmaceutical Packaging Market

This article was originally published in PharmAsia News

Executive Summary

German firm Schott has officially started operation of its Suzhou pharmaceutical packaging plant. The new factory can output 100 million glass bottles for drugs and ampoules annually, with capacity adjustable according to market demand. Currently, the supply will be mainly for the China market. Even though the country's production capacity of glass bottles for drugs is already saturated, Schott believes that its entry will not intensify the competition because it is targeting the high-end market. China is expected to be the world's fifth largest pharmaceutical market by 2010 and biggest by 2050. Schott is thus focusing on China's pharmaceutical packaging business, which contributes to 5 percent of its global revenue and is growing 15 percent yearly. (Click here for more - Chinese Language)
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069755

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel